Skip to main content
logo
T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,600.00
+15.00 (0.58%)
Aug 11, 2026, 3:30 PM KST

T&R Biofab Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Revenue
29,73326,9674,8745,199
Revenue Growth
208.39%453.32%-6.26%-
Gross Profit
8,5466,8282,1081,048
Operating Income
-6,017-8,668-13,299-12,853
Net Income
-31,212-34,944-7,679-13,419
Earnings Per Share
-811.88-1092.93-297.00-527.37
EPS Growth
----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Cash & Investments
7,4027,86117,27651,747
Total Debt
30,13429,56246,05646,021
Net Cash (Debt)
-22,732-21,702-28,7805,725
Net Cash Growth
----
Net Cash Per Share
-591.30-678.76-1113.17225.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-2,307-7,466-11,733-6,963
Capital Expenditures
-2,530-2,146-2,576-12,493
Free Cash Flow
-4,837-9,612-14,309-19,456
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingMar '26 Dec '25 Dec '24 Dec '23
Gross Margin
28.74%25.32%43.24%20.16%
Operating Margin
-20.24%-32.14%-272.87%-247.22%
Pretax Margin
-104.97%-129.58%-157.55%-258.10%
Profit Margin
-104.97%-129.58%-157.56%-258.10%
FCF Margin
-16.27%-35.64%-293.60%-374.22%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
PS Ratio
4.176.6519.1736.97